SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
Clinical trial NCT04767009 · UNKNOWN
Trial details
- NCT number
- NCT04767009
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2024-06-30
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.